Terms: = Ovarian cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280
14 results:
1. Genome-wide repeat landscapes in cancer and cell-free DNA.
Annapragada AV; Niknafs N; White JR; Bruhm DC; Cherry C; Medina JE; Adleff V; Hruban C; Mathios D; Foda ZH; Phallen J; Scharpf RB; Velculescu VE
Sci Transl Med; 2024 Mar; 16(738):eadj9283. PubMed ID: 38478628
[TBL] [Abstract] [Full Text] [Related]
2. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3.
Liu X; Fang Y; Lv X; Hu C; Chen G; Zhang L; Jin B; Huang L; Luo W; Liang G; Wang Y
Cell Death Differ; 2023 Jun; 30(6):1457-1471. PubMed ID: 36932155
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of METTL14 in epithelial ovarian cancer and the effect on cell proliferation, invasion and migration of A2780 and SKOV3 cells].
Wei YS; Yao DS; Li L; Lu Y; Yang XM; Zhang WG
Zhonghua Fu Chan Ke Za Zhi; 2022 Jan; 57(1):46-56. PubMed ID: 35090245
[No Abstract] [Full Text] [Related]
4. Multi-modal Profiling of the Extracellular Matrix of Human Fallopian Tubes and Serous Tubal Intraepithelial Carcinomas.
Renner C; Gomez C; Visetsouk MR; Taha I; Khan A; McGregor SM; Weisman P; Naba A; Masters KS; Kreeger PK
J Histochem Cytochem; 2022 Feb; 70(2):151-168. PubMed ID: 34866441
[TBL] [Abstract] [Full Text] [Related]
5. RAD51AP1 Loss Attenuates Colorectal cancer Stem Cell Renewal and Sensitizes to Chemotherapy.
Bridges AE; Ramachandran S; Tamizhmani K; Parwal U; Lester A; Rajpurohit P; Morera DS; Hasanali SL; Arjunan P; Jedeja RN; Patel N; Martin PM; Korkaya H; Singh N; Manicassamy S; Prasad PD; Lokeshwar VB; Lokeshwar BL; Ganapathy V; Thangaraju M
Mol Cancer Res; 2021 Sep; 19(9):1486-1497. PubMed ID: 34099522
[TBL] [Abstract] [Full Text] [Related]
6. Weekly platinum-based chemotherapy versus 3-weekly platinum-based chemotherapy for newly diagnosed ovarian cancer (ICON8): quality-of-life results of a phase 3, randomised, controlled trial.
Blagden SP; Cook AD; Poole C; Howells L; McNeish IA; Dean A; Kim JW; O'Donnell DM; Hook J; James EC; White IR; Perren T; Lord R; Dark G; Earl HM; Hall M; Kaplan R; Ledermann JA; Clamp AR
Lancet Oncol; 2020 Jul; 21(7):969-977. PubMed ID: 32615110
[TBL] [Abstract] [Full Text] [Related]
7. Early recurrence after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
Tan GHC; Chia CS; Tan SH; Soo KC; Teo MCC
Int J Clin Oncol; 2018 Oct; 23(5):989-998. PubMed ID: 29869757
[TBL] [Abstract] [Full Text] [Related]
8. Incidence and Risk Factors of Lower Extremity Lymphedema After Gynecologic Surgery in ovarian cancer.
Ki EY; Park JS; Lee KH; Hur SY
Int J Gynecol Cancer; 2016 Sep; 26(7):1327-32. PubMed ID: 27400319
[TBL] [Abstract] [Full Text] [Related]
9. Expression profile of col2a1 and the pseudogene SLC6A10P predicts tumor recurrence in high-grade serous ovarian cancer.
Ganapathi MK; Jones WD; Sehouli J; Michener CM; Braicu IE; Norris EJ; Biscotti CV; Vaziri SA; Ganapathi RN
Int J Cancer; 2016 Feb; 138(3):679-88. PubMed ID: 26311224
[TBL] [Abstract] [Full Text] [Related]
10. Hospital discharges for fever and neutropenia in pediatric cancer patients: United States, 2009.
Mueller EL; Walkovich KJ; Mody R; Gebremariam A; Davis MM
BMC Cancer; 2015 May; 15():388. PubMed ID: 25957578
[TBL] [Abstract] [Full Text] [Related]
11. Phase I and pharmacokinetic trial of AP5346, a DACH-platinum-polymer conjugate, administered weekly for three out of every 4 weeks to advanced solid tumor patients.
Campone M; Rademaker-Lakhai JM; Bennouna J; Howell SB; Nowotnik DP; Beijnen JH; Schellens JH
Cancer Chemother Pharmacol; 2007 Sep; 60(4):523-33. PubMed ID: 17308894
[TBL] [Abstract] [Full Text] [Related]
12. Safety and efficacy of lenalidomide (Revlimid) in recurrent ovarian and primary peritoneal carcinoma.
Zhang MM; Chan JK; Husain A; Guo HY; Teng NN
Gynecol Oncol; 2007 Apr; 105(1):194-8. PubMed ID: 17257661
[TBL] [Abstract] [Full Text] [Related]
13. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
[TBL] [Abstract] [Full Text] [Related]
14. Screening of asymptomatic women for endometrial cancer.
Koss LG; Schreiber K; Oberlander G; Moukhtar M; Levine HS; Moussouris HF
Obstet Gynecol; 1981 Jun; 57(6):681-91. PubMed ID: 7015202
[TBL] [Abstract] [Full Text] [Related]
